GLP-1R MODULATING COMPOUNDS

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Saved in:
Bibliographic Details
Main Authors Roberts, Ezra, Yang, Zheng-Yu, Armstrong, Megan K, Chou, Chienhung, Cottell, Jeromy J, Cassidy, James S, Kolahdouzan, Kavoos, Lin, David W, Shapiro, Nathan D, Schroeder, Scott D, Thomas-Tran, Rhiannon, Mitchell, Michael L, Taylor, James G, Wright, Nathan E, Chin, Elbert, Hung, Chao-I
Format Patent
LanguageEnglish
Published 30.03.2023
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.
Bibliography:Application Number: US202217724212